Patient must know all of the possible treatment options when making decision in choosing the best alternative among available treatment plans, this may include Clinical Trials. GCCDC is proud to announce its commitment to facilitate the patients with best possible clinical trials through its Research studies. Our Research team is highly motivated with result based approach towards finding new ways to eradicate cancer. Clinical Trials conclude new and efficient ways in surgery, therapy and other combination of treatments. U.S government agency Food and Drug Administration (FDA) regulates the conduct of Clinical Trials and Research Labs.
Clinical Trials are generally divided in to four Phases
Phase-I is considered the most critical among all phases due to the development of new drug or therapy. Primary goal of Phase-I is to determine the safety level of Clinical Trial at initial stage, which include:
- Doze maximum tolerance
- Drug composition and its comportment
- Drug Side effects
- Determining if side effects are reversible
Phase-I includes those patients with no known cure or whose standard therapy trials have no promising results. After completion of Phase-I, information received through these trials is used in Phase-II.
Phase-II Trials include specific patient population after determining the doze and schedules in Phase-I. Doze is standardized due to its determination in Phase-I for specific group of patients. Phase-II include more patients than Phase-I and it also helps in increasing the effectiveness of the doze. Drugs and therapies passed to Phase-II become standardized treatment and therapy procedures, which can be further evaluated in Phase-III.
Phase-III includes Physicians and other investigators from different institutions participate to conclude the effectiveness of the new drugs or therapy. These new drugs or therapies are evaluated with standardized treatment or therapies on large scale including great number of Patient population sample based on age, sex, race and other factors. Statistical data is gathered from different institutions and medical facilities to prove new drug or therapy effectiveness.
When new drug or therapy is made part of standard treatment procedures, a company or manufacturer takes the most trials and gather statistical data to validate its effectiveness and side-effects. Phase-IV trial includes monitoring and control of the effectiveness of the new drug on human health and its application in different types of cancer treatment programs.